Metabolic and Immunological Phenotyping in Patients With Cancer

Launched by CCTU- CANCER THEME · Feb 24, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at a condition called cachexia, which is a serious weight loss and muscle wasting that can happen in people with certain types of cancer. Specifically, the study focuses on patients who have non-haematological cancers, which means cancers that do not affect the blood or bone marrow. The goal is to better understand the metabolic and immune changes that occur in these patients, helping to improve their care.

To participate in the study, you need to be at least 18 years old and have a confirmed diagnosis of a non-haematological cancer. It's important that you are not currently undergoing certain treatments, like chemotherapy or steroids, and that you do not have any active infections or significant health issues that could complicate your participation. If you decide to join, you will need to attend study visits, where researchers will monitor your health and collect information to help with their research. This study is currently recruiting participants, and everyone is welcome to apply, regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have given written informed consent to participate
• • Be aged 18 years or over at the time of signing the informed consent form
• • Have a histological or cytological diagnosis of a non-haematological cancer
• • Are willing and able to comply with study procedures and visits
• Exclusion Criteria:
• • Active infection, as determined by the investigator based on clinical symptoms and / or fever and / or requirement for antibiotics
• • Current treatment with chemotherapy, oral steroids or other immunosuppressive drugs (within 7 days of baseline investigations or during the study phase)
• • Significant acute, chronic or psychiatric condition or laboratory abnormality which in the judgment of the investigator would place the patient at undue risk or interfere with the study.
• • Intolerance to dairy products
• • Women, who are pregnant, plan to become pregnant or are lactating